Rabbit anti ClofibrateCatalog number: M46s
Clofibrate is a drug used for the treatment of cardiovascular diseases as a lipid-lowering agent. It is found in the water environment in relatively high concentrations, especially in the neighbourhood of large cities and hospitals. It is rapidly degraded to clofibric acid.
Rabbit immune serum
Immunogen: BSA-clofibric acid conjugate
Each vial contains 0.1 ml of serum with 0.02% sodium azide.
Target: Clofibrate, CAS no.: 637-07-0, Solubility: Organic solvents
Species Reactivity: Cross Reactivity 2,4-DB 18% fenitrothion 13% Bezafibrate 11% Fenofibrate 6% Clofibrate 100% Clofibrinic acid 4% Chlorpyriphos 3% MCPA-Na 3% Mecoprop 2% 2,4,5-T 1% 2,4-D 1% 2,4-DP 1% Ciprofibrate 1% Gemfibrozil 1% MCPA 1% Pirimifos-ethyl 1% Diclofenac <0.1% Erythromycine <0.1% Propranolol <0.1%
The antibody may be used in ELISA and IAC. Application notes Depending on conjugate: dilution 1/75,000 . (The titer is defined as the dilution that gives 50 % of the absorbance from the maximum absorbance when tested with ELISA). Suggested concentration to use in ELISA: 1/75,000 from the delivered solution. Plates are coated with 400 ng/ml BSA-conjugated C6-alkylphenol. HRP-conjugated anti-rabbit IgG as a tracer 1/8,000
Store at 4 °C or aliquot and store at -20 °C for longer periods. Precautions should be taken upon storage for longer periods. Problems of long term stability may occur with highly diluted solutions. For long storage purposes in solution the addition of sodium azide at 0.02 % is advised with the appropriate precautions of use.
This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Exalpha Biologicals accepts no liability for any inaccuracies or omissions in this information.